573 related articles for article (PubMed ID: 23790602)
1. Nonpharmacologic approaches to stroke prevention in atrial fibrillation.
Whitlock RP; Hanif H; Danter M
Can J Cardiol; 2013 Jul; 29(7 Suppl):S79-86. PubMed ID: 23790602
[TBL] [Abstract][Full Text] [Related]
2. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
Landmesser U; Holmes DR
Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
[TBL] [Abstract][Full Text] [Related]
3. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
Ramlawi B; Abu Saleh WK; Edgerton J
Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
[TBL] [Abstract][Full Text] [Related]
4. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
5. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
Onalan O; Crystal E
Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
[TBL] [Abstract][Full Text] [Related]
6. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.
Freeman JV; Hutton DW; Barnes GD; Zhu RP; Owens DK; Garber AM; Go AS; Hlatky MA; Heidenreich PA; Wang PJ; Al-Ahmad A; Turakhia MP
Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27307517
[TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
Syed TM; Halperin JL
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
Chiam PT; Ruiz CE
J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
[TBL] [Abstract][Full Text] [Related]
10. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
[TBL] [Abstract][Full Text] [Related]
11. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
Han J; Cheng J; Mathuria N
Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.
Gangireddy SR; Halperin JL; Fuster V; Reddy VY
Eur Heart J; 2012 Nov; 33(21):2700-8. PubMed ID: 23008509
[TBL] [Abstract][Full Text] [Related]
15. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention.
Crystal E; Lamy A; Connolly SJ; Kleine P; Hohnloser SH; Semelhago L; Abouzhar L; Cybulsky I; Shragge B; Teoh K; Lonn E; Sawchuk C; Oezaslan F;
Am Heart J; 2003 Jan; 145(1):174-8. PubMed ID: 12514671
[TBL] [Abstract][Full Text] [Related]
16. Left atrial appendage closure.
Lin AC; Knight BP
Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
[TBL] [Abstract][Full Text] [Related]
17. Nonpharmacologic stroke prevention in atrial fibrillation.
Onalan O; Lashevsky I; Hamad A; Crystal E
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
[TBL] [Abstract][Full Text] [Related]
18. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
Black-Maier E; Piccini JP; Granger CB
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
[TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
20. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
Hanif H; Belley-Cote EP; Alotaibi A; Dvirnik N; Neupane B; Beyene J; Eikelboom JW; Holmes D; Whitlock RP
J Cardiovasc Surg (Torino); 2018 Feb; 59(1):128-139. PubMed ID: 28215062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
